Effects of Gastrostomy on Amyotrophic Lateral Sclerosis
NCT00337402 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 380
Last updated 2006-11-22
Summary
Results about effects of symptomatic treatment on QoL appears conflicting in ALS patients. Moreover no clear effects of gastrotomy have be shown on survival. Prospective study on effect of tube feeding, QoL and survival is performed in 17 teaching hospitals in France (observational study)
Conditions
Sponsors & Collaborators
-
University Hospital, Angers
collaborator OTHER_GOV -
University Hospital, Bordeaux
collaborator OTHER -
University Hospital, Caen
collaborator OTHER -
University Hospital, Grenoble
collaborator OTHER -
University Hospital, Lille
collaborator OTHER -
University Hospital, Limoges
collaborator OTHER -
Neurological department of Lyon University Hospital
collaborator UNKNOWN -
University Hospital, Marseille
collaborator OTHER -
University Hospital, Montpellier
collaborator OTHER -
Central Hospital, Nancy, France
collaborator OTHER -
Centre Hospitalier Universitaire de Nice
collaborator OTHER -
University Hospital, Paris
collaborator OTHER -
University Hospital, Strasbourg
collaborator OTHER -
University Hospital, Toulouse
collaborator OTHER -
University Hospital, Tours
collaborator OTHER -
University Hospital, Clermont-Ferrand
lead OTHER
Principal Investigators
-
Pierre Clavelou · University Hospital, Clermont-Ferrand
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-01-31
- Completion
- 2005-06-30
Countries
- France
Study Locations
More Related Trials
-
Satisfaction of Patients With Amyotrophic Lateral Sclerosis Regarding Home Assisted Teleconsultation
NCT05621213 ·Status: TERMINATED ·Phase: NA
-
Nocturnal PtcCO2 Monitoring in Patients With Amyotrophic Lateral Sclerosis (ALS)
NCT00879593 ·Status: COMPLETED ·Phase: NA
-
Presymptomatic Neuromuscular Junction Defects and Compensatory Mechanisms in ALS
NCT03573466 ·Status: UNKNOWN ·Phase: NA
-
Mitochondrial Functions and Oxidative Stress in ALS Patients
NCT00331812 ·Status: UNKNOWN
-
Fecal Microbiota Transplantation Effect on Amyotrophic Lateral Sclerosis Patients
NCT03766321 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Bioenergetics and Protein Metabolism in Sporadic Amyotrophic Lateral Sclerosis
NCT02969759 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
A Study of the Expression of Nogo and Reticulon Genes in Skeletal Muscle of Patients With Amyotrophic Lateral Sclerosis
NCT00213824 ·Status: TERMINATED
-
Study of Predictive Factors of Progression of Motor Neurone Disease
NCT02360891 ·Status: COMPLETED
-
Effect of Intrathecal Administration of Hematopoietic Stem Cells in Patients With Amyotrophic Lateral Sclerosis (ALS)
NCT01933321 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Spinal Interneuron Excitability in ALS
NCT02429492 ·Status: COMPLETED ·Phase: NA
-
Prognostic Value of a Diaphragmatic Endurance Test in Patients With Amyotrophic Lateral Sclerosis
NCT02528071 ·Status: TERMINATED
-
Registry Study of Assistive Devices, Medicines and Healthcare Measures in ALS, SMA and Other Neurological Diseases.
NCT05852418 ·Status: RECRUITING
-
Neuromuscular Magnetic Stimulation in ALS Patients
NCT03618966 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Tolerability Ultra-high-caloric Food Supplements in Amyotrophic Lateral Sclerosis (ALS)
NCT04172792 ·Status: COMPLETED ·Phase: PHASE1
-
New Therapeutic Strategy in ALS Based on Metabolic Status and Associated Metabolic Pathways.
NCT03984708 ·Status: COMPLETED ·Phase: NA
-
Safety and Tolerability of the Ketogenic Diet in Amyotrophic Lateral Sclerosis (ALS)
NCT01016522 ·Status: TERMINATED ·Phase: PHASE3
-
Neuroinflammation in Amyotrophic Lateral Sclerosis - Mechanisms and Therapeutic Perspectives: a Translational Pilot Study Among ALS Patients
NCT02424669 ·Status: UNKNOWN ·Phase: NA
-
Pharyngeal Electrical Stimulation in Amyotrophic Lateral Sclerosis
NCT03481348 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy and Safety of Deep Cervical Lymph Node-vein Bypass Surgery in ALS Amyotrophic Lateral Sclerosis
NCT06351735 ·Status: NOT_YET_RECRUITING
-
Hyperlipidemia and Statin Therapy in Amyotrophic Lateral Sclerosis
NCT01592084 ·Status: COMPLETED
-
Satisfaction Survey for Amyotrophic Lateral Sclerosis (ALS) Patients Comparing Rooms With and Without Assistive Technology
NCT00718107 ·Status: TERMINATED
-
Ultra-high-caloric, Fatty Diet in ALS
NCT06280079 ·Status: RECRUITING ·Phase: NA
-
Cell Signaling, Reinnervation and Metabolism in Kennedy Disease and Amyotrophic Lateral Sclerosis (ALS)
NCT05107349 ·Status: RECRUITING ·Phase: NA
-
Study of Two Intrathecal Doses of Autologous Mesenchymal Stem Cells for Amyotrophic Lateral Sclerosis
NCT02917681 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Autologous Multipotent Mesenchymal Stromal Cells in the Treatment of Amyotrophic Lateral Sclerosis
NCT03828123 ·Status: COMPLETED ·Phase: PHASE1/PHASE2